India's Dr. Lal PathLabs extends gains on Q4 profit jump

Metropolis Healthcare

10/05/2024 09:35

** Shares of Dr. Lal PathLabs Ltd  DLPA.NS  up 6.6% at
2,379.60 rupees
    ** Medical diagnostics firm reports 49% jump in Q4
consolidated net profit, with revenue growing faster than
expenses
    ** Stock was up 4% ahead of results
    ** Around 570,000 shares traded, 2x 30-day avg volume
    ** Analysts covering DLPA rate it "hold" on avg,
same as Metropolis Healthcare  METP.NS , vs "buy" for Vijaya
Diagnostic Centre  VIJA.NS  - LSEG data
    ** DLPA reduces YTD losses to under 8% but trails METP's 4%
rise and VIJA's 17% growth


 (Reporting by Nandan Mandayam in Bengaluru)
 ((Nandan.Mandayam@thomsonreuters.com; Mobile: +91 9591011727;))